scholarly journals Endophytes of Terrestrial Plants: A Potential Source of Bioactive Secondary Metabolites

2020 ◽  
Vol 8 (7) ◽  
pp. 362-377
Author(s):  
N Nasiruddin ◽  
Guangying Chen ◽  
Yu Zhangxin ◽  
Ting Zhao
2016 ◽  
Vol 1 (1) ◽  
Author(s):  
Brahma N. Singh ◽  
Garima Pandey ◽  
Prateeksha ◽  
J. Kumar

With the advent of green pharmaceuticals, the secondary metabolites derived from plants have provided numerous leads for the development of a wide range of therapeutic drugs; however the discovery of new drugs with novel structures has declined in the past few years. Cryptogams including lichens, bryophytes, and pteridophytes represent a group of small terrestrial plants that remain relatively untouched in the drug discovery process though some have been used as ethnomedicines by various tribes worldwide. Studies of their secondary metabolites are recent but reveal unique secondary metabolites which are not synthesized by higher plants. These compounds can have the potential to develop more potential herbal drugs for prevention and treatment of diseases The present article . deals with the secondary metabolites and pharmacological activities of cryptogams with an objective to bring them forth as potential source of biodynamic compounds of therapeutic value.


2021 ◽  
Author(s):  
Sutaria Devanshi ◽  
Kamlesh R. Shah ◽  
Sudipti Arora ◽  
Sonika Saxena

Biotechnological tools engaged in the bioremediation process are in reality, sophisticated and dynamic in character. For specialized reasons, a broad variety of such devices are employed to produce a safe and balanced environment free of all types of toxins and so make life simpler for humans on planet Earth. Actinomycetes is one of these extremely important and functionally helpful groups. They can be used for a variety of bioremediation objectives, including biotransformation, biodegradation, and many more. Actinomycetes are one of the most varied groups of filamentous bacteria, capable of prospering in a variety of ecological settings because to their bioactive capabilities. They’re famous for their metabolic diversity, which includes the synthesis of commercially useful primary and secondary metabolites. They produce a range of enzymes capable of totally destroying all of the constituents. They are well-known for their ability to produce bioactive secondary metabolites. Members of various genera of Actinomycetes show promise for application in the bioconversion of underutilized urban and agricultural waste into high-value chemical compounds. The most potential source is a wide range of important enzymes, some of which are synthesized on an industrial scale, but there are many more that have yet to be discovered. Bioremediation methods, which use naturally existing microbes to clear residues and contaminated regions of dangerous organic chemicals, are improving all the time. In the realm of biotechnological science, the potential of actinomycetes for bioremediation and the synthesis of secondary metabolites has opened up intriguing prospects for a sustainable environment.


2016 ◽  
Vol 1 (1) ◽  
Author(s):  
Brahma N. Singh ◽  
Garima Pandey ◽  
Prateeksha . ◽  
J. Kumar

<p>With the advent of green pharmaceuticals, the secondary metabolites derived from plants have provided numerous leads for the<br />development of a wide range of therapeutic drugs; however the discovery of new drugs with novel structures has declined in the past few<br />years. Cryptogams including lichens, bryophytes, and pteridophytes represent a group of small terrestrial plants that remain relatively<br />untouched in the drug discovery process though some have been used as ethnomedicines by various tribes worldwide. Studies of their<br />secondary metabolites are recent but reveal unique secondary metabolites which are not synthesized by higher plants. These compounds<br />can have the potential to develop more potential herbal drugs for prevention and treatment of diseases The present article . deals with the<br />secondary metabolites and pharmacological activities of cryptogams with an objective to bring them forth as potential source of<br />biodynamic compounds of therapeutic value.</p><p> </p><p> </p><p><span>DOI: </span><a id="pub-id::doi" href="http://dx.doi.org/10.21756/cba.v1i1.10958">http://dx.doi.org/10.21756/cba.v1i1.10958</a></p>


Planta Medica ◽  
2013 ◽  
Vol 79 (10) ◽  
Author(s):  
LG Malak ◽  
DW Bishay ◽  
AM Abdel-baky ◽  
AM Moharram ◽  
SJ Cutler ◽  
...  

Planta Medica ◽  
2015 ◽  
Vol 81 (11) ◽  
Author(s):  
JJ Araya ◽  
M Chavarría ◽  
A Pinto-Tomás ◽  
C Murillo ◽  
L Uribe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document